Unicycive Therapeutics Inc Stock Ownership - Who owns Unicycive Therapeutics?

Insider buying vs selling

Have Unicycive Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when UNCY insiders and whales buy or sell their stock.

UNCY Shareholders

What type of owners hold Unicycive Therapeutics Inc stock?
Balyasny Asset Management LP4.71%717,349$1.11MInstitution
Nantahala Capital Management LLC4.25%647,416$1.00MInstitution
Vanguard Group Inc0.76%115,057$178.34kInstitution
Geode Capital Management LLC0.63%95,898$148.64kInstitution
Douglas Jermasek0.46%70,400$109.12kInsider
Brigitte Schiller0.27%41,738$64.69kInsider
State Street Corp0.23%35,036$54.31kInstitution
Captrust Financial Advisors0.12%18,800$29.14kInstitution
Tandem Capital Management Corp0.10%15,500$24.03kInstitution
Two Sigma Advisers LP0.10%14,600$22.63kInstitution

1 of 2

UNCY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MTEM13.47%86.53%Net Buying
RGLS4.31%95.69%Net BuyingNet Buying
COCP0.75%99.25%Net BuyingNet Buying
PTN3.96%96.04%Net Buying

Unicycive Therapeutics Stock Ownership FAQ

Who owns Unicycive Therapeutics?

Unicycive Therapeutics (NASDAQ: UNCY) is owned by 11.07% institutional shareholders, 0.74% Unicycive Therapeutics insiders, and 88.19% retail investors. Douglas Jermasek is the largest individual Unicycive Therapeutics shareholder, owning 70,400.00 shares representing 0.46% of the company. Douglas Jermasek's Unicycive Therapeutics shares are currently valued at $123.20k.

If you're new to stock investing, here's how to buy Unicycive Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.